
Gian Lifecare Hits 52-Week Low Amid Broader Sector Resilience Challenges
2025-03-03 14:21:13Gian Lifecare, a microcap in the Hospital & Healthcare Services sector, has hit a new 52-week low, reflecting a significant decline over the past year. The company's stock performance contrasts with the sector's overall resilience, as it continues to trade below key moving averages, indicating ongoing challenges.
Read More
Gian Lifecare Faces Significant Challenges Amidst Healthcare Sector Volatility
2025-02-18 11:57:11Gian Lifecare, a microcap in the Hospital & Healthcare Services sector, has hit a new 52-week low, reflecting significant volatility and underperformance compared to its sector. Over the past year, the company has faced a notable decline, trading below key moving averages and highlighting ongoing challenges in the competitive healthcare market.
Read More
Gian Lifecare Hits 52-Week Low Amid Broader Market Resilience Challenges
2025-02-17 10:06:41Gian Lifecare, a microcap in the Hospital & Healthcare Services sector, has reached a new 52-week low, reflecting a significant decline over the past year. Despite this, the stock has shown some resilience today, outperforming its sector and gaining over the last two days, though it remains below key moving averages.
Read More
Gian Lifecare Faces Persistent Challenges Amid Significant Stock Volatility and Underperformance
2025-02-12 10:07:14Gian Lifecare, a microcap in the Hospital & Healthcare Services sector, has hit a new 52-week low amid significant volatility. The company has underperformed its sector and the broader market over the past year, reflecting ongoing challenges in a competitive healthcare landscape.
Read More
Gian Lifecare Hits 52-Week Low Amidst Sector Underperformance and High Volatility
2025-02-11 13:05:29Gian Lifecare, a microcap in the Hospital & Healthcare Services sector, has reached a new 52-week low, reflecting a significant decline in performance. The stock has shown high volatility and is trading below key moving averages, indicating ongoing challenges in a competitive market, with a notable year-over-year performance drop.
Read More
Gian Lifecare Hits 52-Week Low Amidst Sector Underperformance and High Volatility
2025-02-11 13:05:29Gian Lifecare, a microcap in the Hospital & Healthcare Services sector, has reached a new 52-week low, reflecting a significant decline in performance. The stock has shown high volatility and is trading below key moving averages, indicating ongoing challenges in a competitive market, with a notable year-over-year performance drop.
Read More
Gian Lifecare Faces Significant Challenges Amidst Declining Stock Performance and Market Disparities
2025-01-31 13:05:31Gian Lifecare, a microcap in the Hospital & Healthcare Services sector, is nearing a 52-week low, currently 2.26% above it. The company has underperformed its sector and is trading below key moving averages, reflecting ongoing challenges. Over the past year, it has declined 27.43%, contrasting with the Sensex's gains.
Read More
Gian Lifecare Faces Significant Volatility Amidst Ongoing Healthcare Sector Challenges
2025-01-30 09:35:37Gian Lifecare, a microcap in the Hospital & Healthcare Services sector, has hit a new 52-week low, reflecting significant volatility and a 20.05% decline over the past year. The stock has underperformed its sector and is trading below key moving averages, highlighting ongoing challenges in its market position.
Read More
Gian Lifecare Faces Significant Volatility Amidst Ongoing Healthcare Sector Challenges
2025-01-30 09:35:37Gian Lifecare, a microcap in the Hospital & Healthcare Services sector, has hit a new 52-week low, reflecting significant volatility and a 20.05% decline over the past year. The stock has underperformed its sector and is trading below key moving averages, highlighting ongoing challenges in its market position.
Read MoreBoard Meeting Intimation for Intimation Of Board Meeting To Consider And Approve Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter/ Period Ended 31St December 2024
10-Feb-2025 | Source : BSEGian Life Care Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2025 inter alia to consider and approve As per the captioned subject it is hereby informed that the meeting of the Board of Directors of the Company is scheduled to be held on Friday the 14th day of February 2025 at Kanpur: 1. To interallia consider and approve Unaudited Standalone and Consolidated Financial Results of the Company for the Quarter/ Period ended December 31 2024. 2. Any other business which forms part of the Agenda Paper. Further we hereby inform that the trading window for dealing in shares of the Company has already been closed from 01st January 2025 and shall remain closed till completion of 48 hours after such information is made public for all Directors KMPs Designated Employees and Connected Persons of the Company as defined in the Code.
Outcome Of Board Meeting Held On Thursday November 14 2024
14-Nov-2024 | Source : BSEUnaudited Standalone and Condolidated Results for the period ended September 30 2024
Board Meeting Outcome for Outcome Of Board Meeting Held On Thursday November 14 2024
14-Nov-2024 | Source : BSEPursuant to the provisions of Regulation 30 and other applicable provisions of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 we are pleased to inform you that the Board of Directors at their meeting held today i.e. November 14 2024 has inter-alia considered and approved the following: - 1. Unaudited Standalone and Consolidated Financial results of the Company for the quarter/ half year ended 30th September 2024. (Copy enclosed along with Limited Review Report). The Board Meeting commenced at 05:00 P.M. and concluded at 06.30 P.M. You are requested to kindly take the above information in your records. Thanking You Yours faithfully For GIAN LIFE CARE LIMITED
Corporate Actions
No Upcoming Board Meetings
No Dividend history available
No Splits history available
Gian Lifecare Ltd has announced 6:5 bonus issue, ex-date: 29 Mar 22
No Rights history available